Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into t...
Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
A simple search of the US FDA and the Centers for Medicare and Medicaid Services (CMS) websites demonstrates that the science of personalized medicine is far more advanced than current coverage and reimbursement policies. When one searches the websites of the FDA and CMS for pharmagenomics, personalized medicine and genetic testing, over 1800 hits...
Alternative Titles
Full title
Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2043186003
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2043186003
Other Identifiers
ISSN
1741-0541
E-ISSN
1744-828X
DOI
10.2217/17410541.3.3.345
